CLINICAL_TRIALS
trial_result
· 2025-03-27
Clinical Trial Update: Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS [Phase 3]
Summary
A Phase 3 clinical trial evaluating the efficacy and safety of oral edaravone in amyotrophic lateral sclerosis has been terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanabe Pharma America, Inc. | Conditions: ALS | Phase 3 | Status: TERMINATED | Results posted: 2025-03-27